Skip to main content
. 2009 May 1;58(7):1634–1640. doi: 10.2337/db08-1771

FIG. 2.

FIG. 2.

MFD of the rapidly progressing and nonprogressing participants and significant changes between the groups. A: The nonprogressing dataset shows a no change in MFD (fibers/mm2) over 52 weeks, while the progressing dataset shows a highly significant decrease in MFD. Baseline measurements of triglyceride levels (B) and peroneal motor NCV (C) are significantly different between the progressing and nonprogressing participants. *P < 0.05; ** P < 0.01; *** P < 0.0001.